Wave Life Sciences
88 hedge funds and large institutions have $634M invested in Wave Life Sciences in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 20 closing their positions.
68% more call options, than puts
Call options by funds: $3.35M | Put options by funds: $1.99M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
1.17% more ownership
Funds ownership: 88.91% → 90.08% (+1.2%)
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
12% less funds holding
Funds holding: 100 → 88 (-12)
20% less capital invested
Capital invested by funds: $795M → $634M (-$161M)
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$19M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$15.7M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$10.5M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$3.75M |
| 5 |
JP Morgan Chase
New York
|
+$3.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$17M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$8.04M |
| 3 |
Goldman Sachs
New York
|
-$6.33M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.96M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.54M |
WVE Hedge Fund Activity: Q3 2019 in Review
88 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2019, worth a combined $634M — down 20% from $795M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of WVE and 8 opened new positions — a net loss of 12 holders — while 32 trimmed existing stakes and 34 added.
The largest buyer was Primecap Management, opening a new position worth an estimated $19M. The largest seller was Bridger Management, exiting entirely with an estimated $17M sold.
- 88 institutional investors held Wave Life Sciences (WVE) as of Q3 2019, down from 100 in Q2 2019.
- Funds reported $634M of Wave Life Sciences stock for Q3 2019, down 20% quarter-over-quarter.
- 8 funds opened new Wave Life Sciences positions in Q3 2019 and 20 closed out, a net change of -12 holders.
- The largest Wave Life Sciences buyer in Q3 2019 was Primecap Management, an estimated $19M added.
- The largest Wave Life Sciences seller in Q3 2019 was Bridger Management, an estimated $17M sold.
Based on aggregated 13F filings for Q3 2019.